Lynn Regional Cancer Center West

Boca Raton, Florida 33486

1 studies enrolling now · 15 studies all time

What they study most

Breast Adenocarcinoma, Breast Cancer, Colorectal Cancer, Estrogen Receptor Negative, Estrogen Receptor Positive, HER2 Positive Breast Carcinoma, HER2/Neu Negative, HER2/Neu Positive, Hormone Receptor Positive, Leukemia, Lung Cancer, Malignant Mesothelioma

Studies at this site

• Molecular Genetics Studies of Cancer Patients and Their Relatives — Recruiting now
• Hormone Therapy With or Without Combination Chemotherapy in Treating Women Who Have Undergone Surgery for Node-Negative Breast Cancer (The TAILORx Trial) — Running, not enrolling
• Paclitaxel, Nab-paclitaxel, or Ixabepilone With or Without Bevacizumab in Treating Patients With Stage IIIC or Stage IV Breast Cancer — Completed
• Chemotherapy With or Without Bevacizumab in Treating Patients With Stage IB, Stage II, or Stage IIIA Non-small Cell Lung Cancer That Was Removed By Surgery — Completed
• Doxorubicin Hydrochloride, Cyclophosphamide, and Paclitaxel With or Without Bevacizumab in Treating Patients With Lymph Node-Positive or High-Risk, Lymph Node-Negative Breast Cancer — Running, not enrolling
• Arsenic Trioxide in Treating Patients With Myelodysplastic Syndromes — Stopped early
• Capecitabine and Lapatinib Ditosylate With or Without Cixutumumab in Treating Patients With Previously Treated HER2-Positive Stage IIIB-IV Breast Cancer — Completed
• A Study of Alectinib (CH5424802/RO5424802) in Participants With Anaplastic Lymphoma Kinase (ALK)-Rearranged Non-Small Cell Lung Cancer (NSCLC) — Completed
• Safety and Efficacy of Carboplatin/Paclitaxel and Carboplatin/Paclitaxel/Bevacizumab With and Without Pictilisib in Previously Untreated Advanced or Recurrent Non-small Cell Lung Cancer — Completed
• Pemetrexed Disodium or Erlotinib Hydrochloride as Second-Line Therapy in Treating Patients With Advanced Non-small Cell Lung Cancer — Stopped early
• A Study Evaluating Tarceva in Combination With Avastin Versus Avastin Alone in Treating Metastatic Renal Cell Carcinoma — Completed
• R-Flurbiprofen in Treating Patients With Localized Prostate Cancer at Risk of Recurrence — Status unconfirmed
• Oxaliplatin and Bevacizumab (Avastin™) With Either Fluorouracil and Leucovorin or Capecitabine in Treating Patients With Advanced Colorectal Cancer — Completed
• Alanosine in Treating Patients With Cancer — Completed
• Phase II Study in Patients With Operable Breast Cancer — Status unconfirmed